Evidence map›Paper›PMID 36159009›Full record

SynthesisWorld journal of gastroenterology2022

Current standard values of health utility scores for evaluating cost-effectiveness in liver disease: A meta-analysis.

Tomohiro Ishinuki, Shigenori Ota, Kohei Harada, Masaki Kawamoto, Makoto Meguro, Goro Kutomi, Hiroomi Tatsumi, Keisuke Harada, Koji Miyanishi, Toru Kato and 3 more

Abstract readMeta-Analysis
PubMed Full text at PMC Publisher
In one paragraph

Synthesis in World journal of gastroenterology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. The Role of Patient-Reported Outcomes in Cirrhosis.The American journal of gastroenterology · 2025
    Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Tomohiro IshinukiDepartment of Nursing, Surgical Sciences, Sapporo Medical University, Sapporo 0608556, Japan.
Shigenori OtaDepartments of Surgery, Surgical Science and Oncology, Sapporo Medical University, Sapporo 0608543, Japan.
Kohei HaradaDepartment of Radiology, Sapporo Medical University, Sapporo 0608543, Japan.
Masaki KawamotoDepartments of Surgery, Nemuro City Hospital, Nemuro 0870008, Japan.
Makoto MeguroDepartments of Surgery, Sapporo Satozuka Hospital, Sapporo 0040811, Japan.
Goro KutomiDepartments of Surgery, Surgical Science and Oncology, Sapporo Medical University, Sapporo 0608543, Japan.
Hiroomi TatsumiDepartment of Intensive Care Medicine, Sapporo Medical University, Sapporo 0608543, Japan.
Keisuke HaradaDepartment of Emergency Medicine, Sapporo Medical University, Sapporo 0608543, Japan.
Koji MiyanishiDepartment of Medical Oncology, Sapporo Medical University, Sapporo 0608543, Japan.
Toru KatoDepartments of Surgery, Surgical Science and Oncology, Sapporo Medical University, Sapporo 0608543, Japan.
Toshio OhyanagiDepartment of Liberal Arts and Sciences, Center for Medical Education, Sapporo Medical University, Sapporo 0608556, Japan.
Thomas T HuiDepartments of Surgery, Stanford University School of Medicine, Stanford, 94598, United States.
Toru MizuguchiDepartment of Nursing, Surgical Sciences, Sapporo Medical University, Sapporo 0608556, Japan. tmizu@sapmed.ac.jp.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundHealth utility assessments have been developed for various conditions, including chronic liver disease. Health utility scores are required for socio-economic evaluations, which can aid the distribution of national budgets. However, the standard health utility assessment scores for specific health conditions are largely unknown.

aimTo summarize the health utility scores, including the EuroQOL 5-dimensions 5-levels (EQ-5D-5L), EuroQol-visual analogue scale, short from-36 (SF-36), RAND-36, and Health Utilities Index (HUI)-Mark2/Mark3 scores, for the normal population and chronic liver disease patients.

methodsA systematic literature search of PubMed and MEDLINE, including the Cochrane Library, was performed. Meta-analysis was performed using the RevMan software. Multiple means and standard deviations were combined using the StatsToDo online web program.

resultsThe EQ-5D-5L and SF-36 can be used for health utility evaluations during antiviral therapy for hepatitis C. HUI-Mark2/Mark3 indicated that the health utility scores of hepatitis B patients are roughly 30% better than those of hepatitis C patients.

conclusionThe EQ-5D-5L is the most popular questionnaire for health utility assessments. Health assessments that allow free registration would be useful for evaluating health utility in patients with liver disease.

Indexed as

Hepatitis CLiver DiseasesAntiviral AgentsCost-Benefit AnalysisHealth StatusHumansQuality of LifeSurveys and QuestionnairesAntiviral AgentsEuroQOL 5-dimensions 5-levelsHealth Utilities Index-MarkQuality of lifeRAND-36Short from-36

Identifiers

PMID36159009
PMCPMC9453766

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.